A Japanese study found that immune-related adverse events during checkpoint inhibitor therapy for advanced gastric cancer were independently linked to...

Researchers in India have developed a hybrid CNN-Transformer deep learning model that classifies lung cancer and its major subtypes from...

A prospective study of 327 lung cancer patients found that higher daily step counts measured by smartphone during radiotherapy were...

A survey of a Florida community clinic network found men with HIV were more likely to receive anal cancer screening...

A qualitative study finds that a virtual expressive writing intervention helped rural breast cancer survivors regulate emotions, overcome privacy barriers,...

Five-year results from the KEYNOTE-826 trial confirm that adding pembrolizumab to first-line chemotherapy delivers durable survival benefit for patients with...

A sweeping analysis of more than 21,500 FDA adverse event reports has mapped which anticancer drugs most strongly trigger hand-foot...

A dual PI3K/mTOR inhibitor, VDC597, suppresses signaling, kills canine lymphoma and leukemia cells in vitro, and synergizes with dexamethasone, according...

New preclinical research shows that the ATR inhibitor ceralasertib (AZD6738) synergistically restores and amplifies the antitumor activity of trifluridine in...

The randomized Phase 2 DeLLphi-309 study found that extended-interval tarlatamab dosing every three or four weeks produced efficacy, safety and...